Trial Profile
Pharmacokinetics, pharmacodynamics and safety of intra-articular multiple doses of 500 mcg icatibant in an uncontrolled 13-week multi-center study in patients with symptomatic knee osteoarthritis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Aug 2011
Price :
$35
*
At a glance
- Drugs Icatibant (Primary)
- Indications Osteoarthritis
- Focus Pharmacokinetics
- Acronyms TRICAPEKA
- 11 Aug 2011 New trial record